Non small cell lung cancer xenografts as preclinical models for epidermal growth factor receptor (EGFR) - targeted therapies

被引：0
|
作者：
Behrens, D. [1 ]
Rolff, J. [1 ]
Merk, J. [2 ]
Lee, S. [3 ]
Soong, R. [3 ]
Becker, M. [1 ]
Fichtner, I. [1 ]
机构：
[1] Max Delbruck Ctr Mol Med, Berlin, Germany
[2] Evangel Lungenklin, Berlin, Germany
[3] Natl Univ Singapore, Singapore, Singapore
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 09期
关键词：
D O I：
10.1016/S1359-6349(08)71242-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [1] Epidermal Growth Factor Receptor (EGFR) Targeted Therapies in NonSmall Cell Lung Cancer (NSCLC)
    Metro, Giulio
    Finocchiaro, Giovanna
    Toschi, Luca
    Bartolini, Stefania
    Magrini, Elisabetta
    Cancellieri, Alessandra
    Trisolini, Rocco
    Castaldini, Luciano
    Tallini, Giovanni
    Crino, Lucio
    Cappuzzo, Federico
    REVIEWS ON RECENT CLINICAL TRIALS, 2006, 1 (01) : 1 - 13
  • [2] Epidermal Growth Factor Receptor (EGFR)-targeted Therapies in Esophagogastric Cancer
    Ayyappan, Sabarish
    Prabhakar, Dhivya
    Sharma, Neelesh
    ANTICANCER RESEARCH, 2013, 33 (10) : 4139 - 4155
  • [3] Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
    Harrison, Peter T.
    Vyse, Simon
    Huang, Paul H.
    SEMINARS IN CANCER BIOLOGY, 2020, 61 : 167 - 179
  • [4] Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
    O'Leary, Connor
    Gasper, Harry
    Sahin, Katherine B.
    Tang, Ming
    Kulasinghe, Arutha
    Adams, Mark N.
    Richard, Derek J.
    O'Byrne, Ken J.
    PHARMACEUTICALS, 2020, 13 (10) : 1 - 16
  • [5] Epidermal growth factor receptor (EGFR) inhibition on non-small-cell lung cancer treatment
    Kowalski, Dariusz M.
    Krzakowski, Maciej
    Janowicz-Zebrowska, Anna
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 (04): : 177 - 182
  • [6] Role of epidermal growth factor receptor in lung cancer and targeted therapies
    Liu, Tie-Cheng
    Jin, Xin
    Wang, Yan
    Wang, Ke
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (02): : 187 - 202
  • [7] Epidermal growth factor receptor (EGFR)-targeted therapies in mesothelioma
    Chia, Puey Ling
    Scott, Andrew M.
    John, Thomas
    EXPERT OPINION ON DRUG DELIVERY, 2019, 16 (04) : 441 - 451
  • [8] Tailored treatment with targeted therapies in non-small cell lung cancer (NSCLC) based on the epidermal growth factor receptor gene (EGFR) mutation testing.
    Galvan Ruiz, Saray
    Hernandez Sosa, Maria
    Hernandez Sarmiento, Samuel
    Mori de Santiago, Marta
    Blanco Sanchez, Marla Jesus
    Jimenez Gallego, Pedro
    Saura Grau, Salvador
    Aguiar Bujanda, David
    Hanaelmann Frommelt, Rinaldo
    Fiuza Perez, Maria Dolores
    Batista, Norberto
    Bohn, Uriel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Targeted Therapies in Non-Small Cell Lung Cancer: Emerging Oncogene Targets Following the Success of Epidermal Growth Factor Receptor
    Berge, Eamon M.
    Doebele, Robert C.
    SEMINARS IN ONCOLOGY, 2014, 41 (01) : 110 - 125
  • [10] Targeted Therapies for Non-Small Cell Lung Cancer: An Update on Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Inhibitors
    Kreamer, Kristen
    Riordan, Debbie
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2015, 19 (06) : 734 - 742
12345